Stamford, CT -- (SBWIRE) -- 01/22/2014 -- Wall Street Pennies is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: GTx, Inc. (NASDAQ:GTXI), Whiting USA Trust (NYSE:WHX), Pluristem Therapeutics Inc. (NASDAQ: PSTI), Idera Pharmaceuticals Inc (NASDAQ:IDRA).
GTx, Inc. (NASDAQ:GTXI) opened its last trade at the price of $2.13. Its closing price was $1.97 after losing -6.64% for the day. The company traded with the total volume of 1.09 million shares, while its average trading volume remained 916,154.00 shares. The beta of this stock stands at 1.39. GTx, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecules for the treatment of cancer, cancer supportive care, and other serious medical conditions.
Has GTXI Found The Bottom and Ready To Move Up? Find Out Here
Whiting USA Trust (NYSE:WHX) percentage change plunged -6.63% to close at $5.49 with the total traded volume of 1.23 million shares, along with average volume of 206,579.00 shares. The 52 week range of the stock remained $3.29 - $9.57, while its day lowest price was $5.26. The share price hit the day highest price of $6.18. Whiting USA Trust I is a REIT. The trust was founded in 2007 and is based in Austin, Texas.
Has WHX Found The Bottom And Ready To Gain Momentum? Find Out Here
Pluristem Therapeutics Inc. (NASDAQ: PSTI) traded on volume of 2.05 million shares in the last session against average volume of 404,491.00 shares. The company started its trading session with the price of $4.61 and closed at $4.17 by scoring -5.87%. Pluristem Therapeutics Inc., through its subsidiary, Pluristem Ltd., operates as a bio-therapeutics company. It is engaged in the research, development, and commercialization of standardized cell therapy products and related technologies for the treatment of local and systemic diseases.
Why Should Investors Buy PSTI After the Recent Fall? Just Go Here and Find Out
Idera Pharmaceuticals Inc (NASDAQ:IDRA) started its last trading session with the price of $4.30 and closed at $4.14 by scoring -4.83%. The stock traded with total volume of 2.77 million shares, while the average trading volume remained 2.70 million shares. The beta value of this stock stands at 2.03. Day range for the stock was $3.96 - $4.35. Idera Pharmaceuticals, Inc., a clinical stage biotechnology company, engages in the discovery and development of novel synthetic DNA- and RNA- based drug candidates. It is developing drug candidates designed to modulate immune responses mediated through Toll-like Receptors (TLRs); and evaluating gene silencing oligonucleotides (GSOs), which inhibit the production of disease-associated proteins by targeting RNA.
Will IDRA Get Buyers Even After The Recent Rally? Find Out Here
About Wall Street Pennies:
Wall Street Pennies is always penetrating the market every day for enormous penny stock runs before they happen in order to assist its customers. Our Penny Stock Newsletter also offers free market strategies and analysis from one of the most experienced and well-respected chartists in the penny stock industry.
Carriage Consulting Group, www.wallstreetpennies.com,, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “www.wallstreetpennies.com,”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. Wall Street Pennies as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by www.wallstreetpennies.com, as defined.
Read full Disclaimer at: http://wallstreetpennies.com/financial-disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)